Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study

BACKGROUND: High ERCC1 expression is thought to be related with resistance to chemotherapy based on platinum. The aim of this study was to present our institutional observations regarding to the association of ERCC1 and overall survival (OS) of the lung adenocarcinoma patients who received chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Piljić Burazer, Marina, Mladinov, Suzana, Matana, Antonela, Kuret, Sendi, Bezić, Joško, Glavina Durdov, Merica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745063/
https://www.ncbi.nlm.nih.gov/pubmed/31521181
http://dx.doi.org/10.1186/s13000-019-0885-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745063/
https://www.ncbi.nlm.nih.gov/pubmed/31521181
http://dx.doi.org/10.1186/s13000-019-0885-2

Ejemplares similares